F Oliaei1, A Rasoulinejad, B Seifi. 1. Department of Internal Medicine, Beheshti Hospital, Babol University, Babol, Iran. OL_1964@yahoo.com
Abstract
BACKGROUND AND OBJECTIVE: Ophthalmological complications in transplanted recipients often due to underlying disorders or drug use consist of anterior segment and posterior segment complications. Among the posterior complications, Central serous chorioretinopathy (CSCR) is related to high-dose steroids, stress, or cyclosporine and usually has a good outcome. The aim of this study was to report a case of CSCR as an ophthalmologic complication of renal transplantation. CASE REPORT: A 36-year-old man hospitalized for the treatment of rejection suffered severe visual loss in both eyes. After examination and fluoresein angiography, we diagnosed CSCR due to high-dose steroid therapy for rejection. With tapering of the drug and after about 3 months, visual acuity became normal. CONCLUSION: Visual acuity changes must be followed up carefully in all transplant recipients, but CSCR usually has a good prognosis. If it does not improve, retinal laser therapy is needed.
BACKGROUND AND OBJECTIVE: Ophthalmological complications in transplanted recipients often due to underlying disorders or drug use consist of anterior segment and posterior segment complications. Among the posterior complications, Central serous chorioretinopathy (CSCR) is related to high-dose steroids, stress, or cyclosporine and usually has a good outcome. The aim of this study was to report a case of CSCR as an ophthalmologic complication of renal transplantation. CASE REPORT: A 36-year-old man hospitalized for the treatment of rejection suffered severe visual loss in both eyes. After examination and fluoresein angiography, we diagnosed CSCR due to high-dose steroid therapy for rejection. With tapering of the drug and after about 3 months, visual acuity became normal. CONCLUSION: Visual acuity changes must be followed up carefully in all transplant recipients, but CSCR usually has a good prognosis. If it does not improve, retinal laser therapy is needed.
Authors: Joan Giralt; Amanda Rey; Rafael Villanueva; Socorro Alforja; Ricardo P Casaroli-Marano Journal: Med Oncol Date: 2012-02-22 Impact factor: 3.064